In March 2020 researchers from the USA and Sweden published the results of their study to assess the association between low-dose aspirin (under 160 mg) and hepatocellular carcinoma, liver-related mortality … Read more
Use of low-dose aspirin appears to be associated with a significantly lower risk of hepatocellular carcinoma and lower liver-related mortality, without a significantly higher risk of gastrointestinal bleeding
